470 related articles for article (PubMed ID: 34199427)
1. Structural Features and Toxicity of α-Synuclein Oligomers Grown in the Presence of DOPAC.
Palazzi L; Fongaro B; Leri M; Acquasaliente L; Stefani M; Bucciantini M; Polverino de Laureto P
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34199427
[TBL] [Abstract][Full Text] [Related]
2. Oligomerization and Membrane-binding Properties of Covalent Adducts Formed by the Interaction of α-Synuclein with the Toxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde (DOPAL).
Follmer C; Coelho-Cerqueira E; Yatabe-Franco DY; Araujo GD; Pinheiro AS; Domont GB; Eliezer D
J Biol Chem; 2015 Nov; 290(46):27660-79. PubMed ID: 26381411
[TBL] [Abstract][Full Text] [Related]
3. Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons.
Pujols J; Peña-Díaz S; Lázaro DF; Peccati F; Pinheiro F; González D; Carija A; Navarro S; Conde-Giménez M; García J; Guardiola S; Giralt E; Salvatella X; Sancho J; Sodupe M; Outeiro TF; Dalfó E; Ventura S
Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10481-10486. PubMed ID: 30249646
[TBL] [Abstract][Full Text] [Related]
4. Role of Parkinson's Disease-Linked Mutations and N-Terminal Acetylation on the Oligomerization of α-Synuclein Induced by 3,4-Dihydroxyphenylacetaldehyde.
Lima VA; do Nascimento LA; Eliezer D; Follmer C
ACS Chem Neurosci; 2019 Jan; 10(1):690-703. PubMed ID: 30352158
[TBL] [Abstract][Full Text] [Related]
5. 3,4-Dihydroxyphenylethanol and 3,4-dihydroxyphenylacetic acid affect the aggregation process of E46K variant of α-synuclein at different extent: Insights into the interplay between protein dynamics and catechol effect.
Fongaro B; Cappelletto E; Sosic A; Spolaore B; Polverino de Laureto P
Protein Sci; 2022 Jul; 31(7):e4356. PubMed ID: 35762714
[TBL] [Abstract][Full Text] [Related]
6. DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function.
Plotegher N; Berti G; Ferrari E; Tessari I; Zanetti M; Lunelli L; Greggio E; Bisaglia M; Veronesi M; Girotto S; Dalla Serra M; Perego C; Casella L; Bubacco L
Sci Rep; 2017 Jan; 7():40699. PubMed ID: 28084443
[TBL] [Abstract][Full Text] [Related]
7. 3,4-Dihydroxyphenylacetaldehyde potentiates the toxic effects of metabolic stress in PC12 cells.
Lamensdorf I; Eisenhofer G; Harvey-White J; Nechustan A; Kirk K; Kopin IJ
Brain Res; 2000 Jun; 868(2):191-201. PubMed ID: 10854571
[TBL] [Abstract][Full Text] [Related]
8. Divalent metal ions enhance DOPAL-induced oligomerization of alpha-synuclein.
Jinsmaa Y; Sullivan P; Gross D; Cooney A; Sharabi Y; Goldstein DS
Neurosci Lett; 2014 May; 569():27-32. PubMed ID: 24670480
[TBL] [Abstract][Full Text] [Related]
9. (De)stabilization of Alpha-Synuclein Fibrillary Aggregation by Charged and Uncharged Surfactants.
Loureiro JA; Andrade S; Goderis L; Gomez-Gutierrez R; Soto C; Morales R; Pereira MC
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830391
[TBL] [Abstract][Full Text] [Related]
10. Exploring the role of methionine residues on the oligomerization and neurotoxic properties of DOPAL-modified α-synuclein.
Carmo-Gonçalves P; do Nascimento LA; Cortines JR; Eliezer D; Romão L; Follmer C
Biochem Biophys Res Commun; 2018 Oct; 505(1):295-301. PubMed ID: 30249394
[TBL] [Abstract][Full Text] [Related]
11. Defining α-synuclein species responsible for Parkinson's disease phenotypes in mice.
Froula JM; Castellana-Cruz M; Anabtawi NM; Camino JD; Chen SW; Thrasher DR; Freire J; Yazdi AA; Fleming S; Dobson CM; Kumita JR; Cremades N; Volpicelli-Daley LA
J Biol Chem; 2019 Jul; 294(27):10392-10406. PubMed ID: 31142553
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic manifestation of α-synuclein strains derived from Parkinson's disease and multiple system atrophy in human dopaminergic neurons.
Tanudjojo B; Shaikh SS; Fenyi A; Bousset L; Agarwal D; Marsh J; Zois C; Heman-Ackah S; Fischer R; Sims D; Melki R; Tofaris GK
Nat Commun; 2021 Jun; 12(1):3817. PubMed ID: 34155194
[TBL] [Abstract][Full Text] [Related]
13. Alteration of Structure and Aggregation of α-Synuclein by Familial Parkinson's Disease Associated Mutations.
Sahay S; Ghosh D; Singh PK; Maji SK
Curr Protein Pept Sci; 2017; 18(7):656-676. PubMed ID: 26972727
[TBL] [Abstract][Full Text] [Related]
14. Insight into the molecular mechanism underlying the inhibition of α-synuclein aggregation by hydroxytyrosol.
Palazzi L; Leri M; Cesaro S; Stefani M; Bucciantini M; Polverino de Laureto P
Biochem Pharmacol; 2020 Mar; 173():113722. PubMed ID: 31756328
[TBL] [Abstract][Full Text] [Related]
15. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
[TBL] [Abstract][Full Text] [Related]
16. Physicochemical characterization of the G51D mutation of α-synuclein that is responsible for its severe cytotoxicity.
Murata T; Tochio N; Utsunomiya-Tate N
Neurosci Lett; 2021 Aug; 760():136077. PubMed ID: 34161822
[TBL] [Abstract][Full Text] [Related]
17. Scutellarin inhibits the uninduced and metal-induced aggregation of α-Synuclein and disaggregates preformed fibrils: implications for Parkinson's disease.
Zaidi FK; Deep S
Biochem J; 2020 Feb; 477(3):645-670. PubMed ID: 31939603
[TBL] [Abstract][Full Text] [Related]
18. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
Sharma N; Rao SP; Kalivendi SV
Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
[TBL] [Abstract][Full Text] [Related]
19. Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson's Disease.
Deas E; Cremades N; Angelova PR; Ludtmann MH; Yao Z; Chen S; Horrocks MH; Banushi B; Little D; Devine MJ; Gissen P; Klenerman D; Dobson CM; Wood NW; Gandhi S; Abramov AY
Antioxid Redox Signal; 2016 Mar; 24(7):376-91. PubMed ID: 26564470
[TBL] [Abstract][Full Text] [Related]
20. 3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis.
Burke WJ; Li SW; Williams EA; Nonneman R; Zahm DS
Brain Res; 2003 Nov; 989(2):205-13. PubMed ID: 14556942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
